The total number of subjects in the present study was relatively small, yet it fulfilled the minimal number required from the sample size calculation. From the demographic data, there was no significant difference in the age between the two groups. Aging is responsible for a general decrease in the function of tissues and organs, including the reproductive tissues and organs. The effects of aging on male fertility were studied by numerous studies. Robertshaw, et al., found that advanced paternal age has an adverse impact on ART outcomes [13]. Other study also found that the ability of spermatozoa to performed fertilization is inversely correlated with the age [14]. The effects of paternal age on fertility remain controversial. Wu, et al., found that increased paternal age had no impact on fertilization rate, embryo quality, and miscarriage rate after controlling the maternal age [15]. Ferreira, et al., who conducted a study to 1024 couples undergoing ICSI (intracytoplasmic sperm injection), also found no correlation between paternal age and sperm parameters or pregnancy rate [16]. Alfaraj and Yunus conducted a study to 451 couples and also found that advancing paternal age had no significant correlation with the outcomes of semen analysis parameters and IVF in infertile couples [17]. This study found no significant difference between age of the two groups. This might be caused by the subject’s selection method used in this study. The fertile group was taken from men proven to have living children and obtained from secondary infertile couples due to female factors so that the median and the range of the age were similar between the two groups.
We define the fertile men were those who have normal semen parameter (concentration, motility, and morphology), even though the subsequent subfertility condition might have correlated with the male factor that can not be seen in semen analysis result, such as body mass index (BMI). Although the data about male’s BMI were not provided, but it has been under a lot of suspicion as the cause of male infertility. There are emerging facts confirming that obesity negatively affects male reproductive potential not only by reducing sperm quality, but in particular, by altering the physical and molecular structures of germ cells in the testes, and ultimately by affecting the maturation and functions of sperm cells [18]. Anifandis, et al., found that BMI of men did not correlate with sperm parameters, but influenced the quality of the produced embryos which, in turns, influenced the pregnancy rates [19]. Similar result was also found by Petersen, et al., that showed couples with both partners having BMI > 25 kg/m2 had the lowest odds of live birth when compared to couples with both partners having BMI < 25 kg/m2 in IVF [20]. In contrast with those studies, Kupka, et al., retrospectively analyzed data retrieved from the National German IVF Registry, which covered 12 years and included 650,452 cycles, and found that the highest clinical pregnancy rates for both IVF and ICSI were seen in normal weight females with obese male partners (P = 0.0028) [21]. However, because none of those studies were randomized controlled trials, several potential confounders and biases might have influenced the findings.
This study found that sperm concentration, total motility, progressive motility, morphology, and total sperm count values were significantly lower in the infertile group compared to the fertile group, while semen volume did not differ. Although total sperm count, total motility, and progressive motility were significantly lower in infertile group, the median values were considered normal. It was considered that the normal median value of the total sperm count could be the result of the length of abstinence. Both groups have abstinence/delay of 7 days. The recommended abstinence delay for semen analysis are 2–7 days [12]. Many studies found that semen volume and concentration (resulted in total sperm count) increased with the increasing length of abstinence. Carlsen, et al., studied 419 semen samples with abstinence interval of 2–7 days and found that there was increased in semen volume and concentration after 4 days of abstinence and succeeding days, and there was no effect on motility and total motile spermatozoa with increased duration of abstinence [22]. Sunanda, et al., studied 730 men with abstinence interval of 2–7 days and found that semen volume and total count increased with the increasing abstinence period, while sperm motility and vitality declined after 5 days of abstinence [23]. The effects of abstinence length on sperm motility in previous studies were contradicted by a more recent study by Agarwal, et al., who conducted semen analysis by grouping the abstinence interval into three categories: short interval (1 day), the recommended interval of the World Health Organization (WHO) (2–7 days), and long interval (9–11 days). The study found significant increase in volume, total sperm count, total motility, and DNA fragmentation between the short and the recommended abstinence interval (P < .05); and between the recommended and the long abstinence interval (P < .05) [24].
In this study, the median value of sperm DFI was significantly higher in the infertile group compared to the fertile group (Table 1). The values of the three sperm parameters are also significantly lower in the infertile group. These results are consistent with the study of Sergerie, et al., in 2005 that found mean value of sperm DFI in the infertile group was significantly higher than in the fertile group (40.9 ± 14.3% compared to 13.1 ± 7.3%) and the mean sperm concentration in infertile group also significantly lower compared to the fertile group (62.9 ± 33.2 × 106/ml compared to 102.4 ± 66.4 × 106/ml) [25]. Similar result was also reported in a study that assessed the degree of DFI in patients dealing with infertility. Sperm DFI was significantly higher in patients with infertility compared to those of control (22.2 ± 5.6% vs. 16.7 ± 0.7%; p < 0.05) [26]. From these results, it may be concluded that sperm DFI determination could be used to distinguish infertile men from fertile men.
AUC value of sperm DFI was 0.862 (p < 0.001; 95% CI 0.783, 0.941) with sensitivity of 80.8% and specificity of 86.1%. Statistically, AUC value in the range of 80–90% has a good diagnostic strength [27]. This value is 11.8% higher than the highest AUC value of semen analysis that routinely performed in infertility workup (Table 2). This result indicates that clinically, sperm DFI has better diagnostic strength than semen analysis. Sperm DFI also has a stronger predictive value compared to free sperm DNA for the success of pregnancy in IVF and ICSI patients (AUC = 0.7; p < 0.05 compared to AUC = 0.6; p > 0.05) [28]. A meta-analysis by Cui, et al., also supports this result that the sperm DFI may be used to distinguish the sperm of infertile men from fertile men with AUC value of 0.921, and sensitivity of 80% and specificity of 83% [29].
The expected benefit of this study is to increase the outcome of infertility management in infertile couple population. Sperm DFI can well-distinguish infertile men from fertile men with positive predictive value of 92.6% at 26.1% cut-off point. Similar result was reported in a study comparing DNA fragmentation of neat and swim-up spermatozoa to predict pregnancy following ICSI. The cut-off value of the neat spermatozoa that resulted in 80% of pregnancy rate was 26% [30]. There are only a few published papers that specifically used SCD test (or Halosperm test) to assess male infertility and reported the correlation with IVF or ICSI outcomes. Two published papers reported that sperm DFI measured with Halosperm had no impact on the embryo quality and the ongoing pregnancy rates in IVF or ICSI. These studies, however, used different cut-off points from the present study (30 and 35% DFI) [31, 32]. Due to the higher cut-off points, the fact that extremely high DNA damages are associated with total pregnancy failure should not be ruled out. A new study that uses 26% DFI as a cut-off point is needed to establish the impact of sperm DFI measured with Halosperm on male infertility.
In this study, the prevalence ratio for sperm DFI ≥ 26.1% was 2.84 (95% CI, 1.86, 4.33). Thus, it may be concluded that a man with sperm DFI of ≥ 26.1% has 2.84 times greater risk for infertility than men with sperm DFI of < 26.1%. These results are consistent with a cohort study that found the most predictive cut-off point for pregnancy was sperm DFI of > 25.5% with negative predictive value of 72.7% and the odds ratio for sperm DFI < 25.5% was 3.6 (95% CI; 1.66, 7.82) [33].
